Indivior (INDV) Q4 FY25 earnings call

Indivior completed Phase I of its Action Agenda, generating momentum for SUBLOCADE and strengthening its financial profile. The company is now executing Phase II, "Accelerate," focusing on mid-teens SUBLOCADE dispense unit growth and significant adjusted EBITDA and cash flow expansion in 2026. Management also outlined a disciplined capital deployment strategy, including a new share repurchase program and criteria for future business development.